Evidence map›Paper›PMID 33834491›Full record

ArticleContact dermatitis2021

Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.

Luca Stingeni, Daniela Francisci, Leonardo Bianchi, Katharina Hansel, Marta Tramontana, Francesco Di Candilo, Massimo Raffaele Mannarino, Matteo Pirro

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Contact dermatitis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Luca StingeniDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.ORCID 0000-0001-7919-8141
Daniela FrancisciInfectious Diseases Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Leonardo BianchiDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Katharina HanselDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.ORCID 0000-0002-6674-4278
Marta TramontanaDermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Francesco Di CandiloInfectious Diseases Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Massimo Raffaele MannarinoInternal Medicine Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Matteo PirroInternal Medicine Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentPatch TestsAcute Generalized Exanthematous PustulosisAgedAnti-Bacterial AgentsAntiviral AgentsCeftriaxoneCOVID-19Drug Therapy, CombinationFemaleHumansSARS-CoV-2Anti-Bacterial AgentsAntiviral AgentsCeftriaxoneAGEP/TEN overlapceftriaxoneCOVID-19patch testSARS-CoV-2 infectionsevere cutaneous adverse reaction

Identifiers

PMID33834491
PMCPMC8250611
OpenAlexW3148178922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.